Bittner S, Simon OJ, Gbel K, Bien CG, Meuth SG, Wiendl H
Exenatide, a twice-daily formulation (exenatide twice daily), was developed based on exendin-4, which is derived from the saliva of the American poisonous lizard (Gila monster) and shows 53% homology to human GLP-1 [35]
Absorption and Effectiveness The jelly format of SSUNSU allows for better absorption of glutathione and other nutrients compared to traditional capsules or tablets
Modulation of glucagon-like peptide-1 (GLP-1) potency by endocannabinoid-like lipids represents a novel mode of regulating GLP-1 receptor signaling
HernandezAFGreenJBJanmohamedSAgostinoDGrangerRBJonesCBet alAlbiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (harmony outcomes): a double-blind, randomised placebo-controlled trial